Doximity, Inc.

Listed Company

DOCSCIK 0001516513NYSELarge AcceleratedServices-Computer Programming ServicesDelawareFY ends Mar 31

Period

FY 2026

Revenue

$644.86M

Net Income

$196.05M

Total Assets

$1.12B

Equity

$950.84M

Shares Out

183.06M

Op. Cash Flow

$326.46M

DOCS$21.52−65.08% · past yearDBEQ Basic

Daily closing prices

Business

Doximity, Inc. is a physician-first technology platform serving millions of registered medical professionals across all U.S. specialties. The company offers free membership tools including a professional network, clinical AI suite (Ask, Scribe, Dialer), telehealth, scheduling, and secure messaging to streamline workflows and clinical productivity. Doximity generates revenue through subscription-based Marketing Solutions for pharmaceutical manufacturers and health systems, Hiring Solutions for recruitment, and Workflow Solutions (telehealth, documentation, scheduling) sold to healthcare organizations; the platform benefits from network effects connecting members, customers, and clinical decision-making.

Summary from 10-K filed 2026-05-19

Financials

Consolidated Statement of Income

Year Ended · In millions, except per-share amounts

Concept	FY 2026 2026-03-31	FY 2025 2025-03-31	FY 2024 2024-03-31	FY 2023 2023-03-31	FY 2022 2022-03-31
Revenue	645	570	475	419	344
Cost of revenue	70	56	51	53	40
Gross profit	575	515	425	366	304
Research and development	131	93	82	80	62
Sales and marketing	164	146	133	124	92
General and administrative	65	46	38	37	36
Restructuring and impairment charges	0	2	8	—	—
Total operating expenses	360	287	261	240	190
Income from operations	215	228	164	125	114
Other income, net	35	36	21	—	—
Income before income taxes	250	264	185	133	114
Provision for income taxes	54	40	38	20	−41
Net income	196	223	148	113	155
Basic (in dollars per share)	1.05	1.19	0.78	0.58	0.82
Diluted (in dollars per share)	0.98	1.11	0.72	0.53	0.7
Basic (in shares)	187	187	190	193	163
Diluted (in shares)	199	201	206	213	191

Consolidated Balance Sheet

As of · In millions, except per-share amounts

Concept	FY 2026 2026-03-31	FY 2025 2025-03-31	FY 2024 2024-03-31	FY 2023 2023-03-31	FY 2022 2022-03-31
Cash and cash equivalents	219	210	97	158	113
Marketable securities	529	706	666	683	685
Accounts receivable, net of allowance for doubtful accounts of $1,345 and $1,937 as of March 31, 2026 and 2025, respectively	145	128	101	107	81
Prepaid expenses and other current assets	51	45	49	27	19
Total current assets	944	1,089	913	975	904
Property and equipment, net	18	14	12	11	8
Deferred income tax assets	32	60	45	35	49
Operating lease right-of-use assets	7	9	12	14	1
Intangible assets, net	35	23	27	32	8
Goodwill	85	68	68	68	19
Other assets	2	2	1	2	2
Total assets	1,124	1,264	1,079	1,137	991
Accounts payable	4	1	2	1	463,000
Accrued expenses and other current liabilities	43	38	—	—	—
Deferred revenue, current	106	114	99	105	85
Operating lease liabilities, current	2	2	2	2	642,000
Total current liabilities	155	156	147	140	111
Deferred revenue, non-current	400,000	280,000	211,000	198,000	78,000
Operating lease liabilities, non-current	8	10	12	14	447,000
Contingent earn-out consideration liability, non-current	0	6	11	16	0
Other liabilities, non-current	9	9	7	1	956,000
Total liabilities	173	182	178	171	113
Commitments and contingencies (Note 14)	—	—	—	—	—
Preferred stock, $0.001 par value; 100,000 shares authorized as of March 31, 2026 and 2025, respectively; zero shares issued and outstanding as of March 31, 2026 and 2025, respectively	0	0	0	0	0
Class A and Class B common stock, $0.001 par value; 1,500,000 shares authorized as of March 31, 2026 and 2025, respectively; 183,060 and 188,875 shares issued and outstanding as of March 31, 2026 and 2025, respectively	183,000	189,000	187,000	194,000	192,000
Additional paid-in capital	1,002	894	824	762	703
Accumulated other comprehensive income	28,000	1	−3	−14	−15
Retained earnings (accumulated deficit)	−51	187	80	218	191
Total stockholders' equity	951	1,083	901	966	879
Total liabilities and stockholders equity	1,124	1,264	1,079	1,137	991

Consolidated Statement of Cash Flows

Year Ended · In millions, except per-share amounts

Concept	FY 2026 2026-03-31	FY 2025 2025-03-31	FY 2024 2024-03-31	FY 2023 2023-03-31	FY 2022 2022-03-31
Depreciation and amortization	14	11	10	10	5
Deferred income taxes	32	−12	−9	13	−41
Stock-based compensation, net of amounts capitalized	122	72	51	48	31
Non-cash lease expense	2	2	2	2	1
Accretion of discount on marketable securities, net	−8	−12	−5	3	4
Amortization of deferred contract costs	14	10	9	9	10
Impairment of long-lived assets	0	2	0	0	—
Other	314,000	270,000	3	3	410,000
Accounts receivable	−17	−27	4	−26	−31
Prepaid expenses and other assets	−8	3	−20	−3	−9
Deferred contract costs	−14	−12	−9	−8	−10
Accounts payable, accrued expenses and other liabilities	4	−663,000	8	−195,000	9
Deferred revenue	−8	15	−6	18	2
Operating lease liabilities	−2	−2	−2	−213,000	−1
Net cash provided by operating activities	326	273	184	180	127
Cash paid for acquisition, net of cash acquired	−27	0	0	−54	0
Purchases of property and equipment	0	0	−147,000	−2	−2
Purchases of intangible assets	−62,000	0	0	—	—
Internal-use software development costs	−9	−7	−6	−4	−4
Purchases of marketable securities	−389	−676	−473	−191	−1,317
Maturities of marketable securities	561	635	435	83	48
Sales of marketable securities	10	17	75	107	634
Net cash provided by (used in) investing activities	147	−29	31	−60	−641
Proceeds from issuance of common stock upon exercise of stock options and common stock warrants	10	20	13	10	13
Proceeds from issuance of common stock in connection with the employee stock purchase plan	4	4	3	5	1
Taxes paid related to net share settlement of equity awards	−41	−27	−7	−4	−817,000
Repurchase of common stock	−432	−120	−281	−85	−3
Payment of contingent consideration related to a business combination	−5	−5	−5	0	0
Payment of excise taxes on share repurchases	0	−1	0	0	—
Net cash used in financing activities	−464	−131	−277	−74	560
Net increase (decrease) in cash and cash equivalents	10	113	−61	45	46
Cash paid for taxes, net of refunds	22	56	51	5	206,000
Equity awards included in purchase consideration	10	0	0	—	—
Capitalized stock-based compensation for internal-use software development costs	4	2	1	865,000	497,000
Excise tax payable on share repurchases	2	0	1	0	0

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro

Frequently asked questions

What is Doximity, Inc.'s CIK number?

Doximity, Inc.'s SEC CIK number is 0001516513 (1516513). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.

Where can I find Doximity, Inc.'s SEC filings?

All of Doximity, Inc.'s EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.

When did Doximity, Inc. last report earnings?

Doximity, Inc. (DOCS) most recently filed an earnings 8-K with the SEC on May 13, 2026, furnishing its results under Item 2.02 (Results of Operations and Financial Condition). The earnings press release is attached to that filing (accession 0001516513-26-000017). This is Doximity, Inc.'s most recent earnings filing of record — not a forecast of its next earnings date.

What is Doximity, Inc.'s most recent earnings 8-K?

Doximity, Inc.'s latest earnings 8-K (Item 2.02) was filed May 13, 2026 under accession 0001516513-26-000017. It carries the quarterly or annual earnings press release — the earliest official, SEC-filed version of the results.

View Doximity, Inc.'s latest earnings 8-K →
Look up any company's CIK number →